Combination therapy with S-1 and interferon-α in hepatocellular carcinoma patients with lung metastasis

Molecular and Clinical Oncology
Hirofumi AkitaHiroaki Nagano

Abstract

Managing extrahepatic recurrence in hepatocellular carcinoma (HCC) patients is crucial for improving prognosis. The present study aimed to investigate the effectiveness of using combination therapy with S-1 and interferon (IFN)- α in HCC patients with lung metastasis. Of the 646 patients who underwent radical surgery for HCC at our institute, 62 developed their first distant metastasis in the lung. Among these patients, 11 received S-1 combination therapy, while the remaining 51 patients received other conventional therapy, such as 5-fluorouracil and cisplatin or best supportive care. We retrospectively evaluated the toxicity and efficiency of combination therapy with S-1 and IFN- α. Hematological toxicity was observed in 5 patients and was grade 1 or 2 in all cases, except 1 patient (9.1%) who developed grade 3 leukopenia. Non-hematological toxicity was observed in 6 patients and was grade 1 in all cases, except 1 patient who exhibited a grade 2 increase of serum bilirubin levels. No patient required discontinuation of the S-1 combination therapy and no treatment-related mortality was reported during this study. Patients who received S-1 treatment exhibited significantly better survival after distant recurrence (SADR) compared...Continue Reading

References

Aug 31, 2000·Radiology·S KatyalR L Baron
Oct 28, 2003·Annals of Surgery·Masami MinagawaNorihiro Kokudo
Mar 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bunzo NakataKosei Hirakawa
Jun 16, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anna K NowakMichael Findlay
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Jul 12, 2005·Oncology·Hideki UenoChigusa Morizane
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Jun 14, 2006·American Journal of Surgery·Yoshito TomimaruShingi Imaoka
May 6, 2008·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Masafumi KawamuraUNKNOWN Metastatic Lung Tumor Study Group of Japan
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Aug 1, 2008·World Journal of Surgery·Fengshi ChenHiroshi Date
Oct 7, 2008·World Journal of Gastroenterology : WJG·Jong-Bum KwonHyeon-Woo Lim
Nov 20, 2008·British Journal of Cancer·T F GretenN P Malek
Dec 10, 2008·Pharmacology & Therapeutics·Richard D EgletonPiyali Dasgupta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.